Press Release

JP Selecta, Global Good Collaboration Brings Novel Microbiology Incubator to Market

December 17, 2018 Barcelona, Spain

Microbiologists now have ability to adequately conduct microbiological tests in laboratories with unreliable access to power.

Intellectual Ventures’ Global Good fund signed a licensing agreement with J.P. Selecta to manufacture and distribute a microbiological incubator for laboratories in low-resource settings.

“This incubator will help frontline health workers perform important culture-based microbiological tests in places where power is unreliable – a critical step in managing diseases like tuberculosis, sepsis, enteric and diarrheal diseases, and sexually-transmitted bacterial infections,” said Maurizio Vecchione, Executive Vice President of Global Good.

Accurate detection and surveillance of some infectious diseases involves studying bacteria by growing it in devices that maintain optimal temperature and other atmospheric conditions. High unit costs, frequent power outages, lack of adequate temperature monitoring and ambient temperature control, and high maintenance requirements associated with currently available microbiological incubators have severely limited their usage and effectiveness in low-resource laboratories.

The INCUDIGIT-SV 30 can operate without a reliable power supply or ambient climate control capabilities. Its internal sample chamber compartment capacity is 31 liters to support the need of a mid-sized microbiology laboratory. It has removable, adjustable shelves; an optional temperature data logging system; a user-adjustable temperature setpoint of 35°C, 36° C or 37° C; and a LED temperature display.

"From the first moment we were presented, in 2016, with the new microbiology incubator project by Global Good we were excited about the project. For many laboratories or health centers with low resources and deficient electrical power supplies, having a culture incubator such as the INCUDIGIT-SV 30 provides the opportunity to perform microbiological cultures, obtaining diagnoses in shorter time period, and in the process saving lives," said José Antonio Ejarque, Commercial Director of JP Selecta.

About Intellectual Ventures’ Global Good Fund

Global Good is dedicated to inventing technology for humanitarian impact. Millions of people suffer and die each year in poor countries from causes that humanity has the scientific and technical ability to solve. Funded by Bill Gates and focused on a shared vision with Nathan Myhrvold, Global Good invents technology to solve some of humanity's most daunting problems. Global Good does this by collaborating with leading humanitarian organizations, forward-looking governments, research institutions, and corporate and private sector partners that bring our inventions to market.  

About J.P. Selecta

JP Selecta is a family owned company which was founded in 1950 by Mr. Joaquim Puig.  The mission of the company is to satisfy the materials and laboratory equipment needs of laboratories.

Mr. Jordi Puig is the General Director, who directs THE SELECTA GROUP.

The SELECTA group consists of three companies:

J.P. SELECTA, S.A.U. – Designs and manufactures laboratory equipment

COMECTA, S.A.U. – Laboratory equipment wholesaler

AQUISEL, S.L. – Specializes in the manufacturing of disposable blood sample collection products

More Buzz From IV

Happy Birthday to The Explorer Who Knows No Bounds
This week we celebrate the 75th birthday of a scientist who fundamentally changed how we think about the universe and has become an emblem of intellectual curiosity for scientists, thinkers and innovators alike. Read More
Holiday Greetings from Intellectual Ventures
Our very best for a wonderful holiday season. See you in 2017! Read More
Top Nine Invention Stories from March
March marks Women’s History Month and International Women’s Day celebrations around the world. At Intellectual Ventures, we commend the contributions of women to the field of invention, and work to support more women and girls to pursue careers in STEM. Read More